Genitourinary Pathology

1. Torre LA, Bray F, Siegel RI, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

   Article  PubMed  Google Scholar 

2. Gandaglha G, Leni R, Bray F. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877–92.

   Article  Google Scholar 

3. Humphrey PA. Histopathology of prostate cancer. Cold Spring Harb Perspect Med. 2017;7:1–21.

   Article  Google Scholar 

4. Epstein JL, Allsbrook WCJ, Amin MB, et al. ISUP grading committee. The 2005 International Society of Urologic Pathology (ISUP) consensus conference on Gleason grading of prostate adenocarcinoma. Am J Surg Pathol. 2005;29:1228–42.

   Article  PubMed  Google Scholar 

5. Haffner MC, Zwart W, Roudier MP, et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18(2):79–92.

   Article  PubMed  Google Scholar 

6. Merrill RM, Wiggins CL. Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate. Urol Oncol. 2002;7(5):213–9.

   Article  PubMed  Google Scholar 

7. Jenck S, Helgstrand JT, Rader MA, et al. The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nation-wide analysis. Scand J Urol. 2018;52(5–6):358–63.

   Article  Google Scholar 

8. Bell KJL, DelMar C, Wright G, et al. Prevalence of incidental prostatic carcinoma: a systemic review of autopsy studies. Int J Cancer. 2015;137:1749–57.

   Article  CAS  PubMed  PubMed Central  Google Scholar 

9. Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: a review. JAMA. 2020;324(10):1980–91.

   Article  CAS  PubMed  Google Scholar 

10. Al-hamadi H, Netto GJ. Molecular pathology of urothelial carcinoma. Surg Pathol Clin. 2021;14(3):403–14.

    Article  Google Scholar 

11. Lobo N, Shariat SF, Guo CC, et al. What is the significance of variant histology of urothelial carcinoma? Eur Urol Focus. 2020;6:653–63.

    Article  PubMed  Google Scholar 

12. Massan F, Ciccorese C, Hes O, et al. The tumor entity denominated “clear cell papillary renal cell carcinoma” according to the WHO 2016 new classification have the clinical characters of a renal cell adenoma as does harbor benign outcome. Pathol Oncol Res. 2018;23(3):447–56.

    Google Scholar 

13. Alshenawy HA. Immunohistochemical panel for differentiating renal cell carcinoma with clear cell papillary features. Pathol Clin Oncol Res. 2015;21(4):893–9.

    Article  CAS  Google Scholar 

14. Williamson SR, Zhang S, Eble JN, et al. Clear cell papillary renal cell carcinoma-like tumor in patients with Von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinomas. Am J Surg Path. 2013;37(8):1131–9.

    Article  PubMed  Google Scholar 

15. Farre X, Sinha AA. Gleason, Donald A. (1920–2008). In: van den Tweel JG, editor. Pioneers in pathology. In: van Krieken JHJM, series editor. Encyclopedia of pathology. Cham:Springer; 2017. p. 185–188.

    Google Scholar 

16. Snyder A. Obituary. Donald Gleason. Lancet. 2009;373:540.

    Article  Google Scholar 

17. Phillips JL, Sinha AA. Patterns, art and context. Donald Floyd Gleason and the development of the Gleason grading system. Urology. 2009;74:497–503.

    Article  PubMed  Google Scholar 

18. Gleason DF. Classification of prostate carcinomas. Cancer Chemother Rep. 1966;30:125–8.

    Google Scholar 

19. Harley RA. Mostofi, Fathollah Keshvar (1911–2003). In: van den Tweel JG, editor. Pioneers in pathology. In: van Krieken JHJM, series editor. Encyclopedia of pathology. Cham:Springer; 2017. p. 395–399.

    Google Scholar 

20. Sesterhenn I. Legends in urology. Fatollah Keshvar “Kash” Mostofi MD. Can J Urol. 2014;21(3):7256–8.

    PubMed  Google Scholar 

21. Mostofi FK. A study of 2678 patients with initial carcinoma of the bladder survival rates. J Urol. 1956;75(3):480–91.

    Article  CAS  PubMed  Google Scholar 

22. Mostofi FK, Townend FM, Sternbridge V. Causes of sudden and unexpected death in aircrew. Aerosp Med. 1960;31:745–8.

    Google Scholar 

Download references